Open Access

Serum calcium level is related to both intima-media thickness and carotid atherosclerosis: a neglect risk factor in obese/overweight subjects

Journal of Translational Medicine201210:114

https://doi.org/10.1186/1479-5876-10-114

Received: 29 March 2012

Accepted: 23 May 2012

Published: 6 June 2012

Abstract

Background

Experimental studies suggested that high serum calcium may be important in the pathogenesis of vascular diseases. Since calcium seems to affect specifically the cerebrovascular district, aim of this study was to determine the relation between serum calcium levels, within normal range, and subclinical atherosclerosis in the carotid arteries, in a population of obese/overweight subjects.

Methods

In our retrospective study we included 472 subjects (59% female) with body mass index equal to or more than 25 kg/m2. They underwent a physical examination, a biochemical assessment (including calcium evaluation) and a B-mode ultrasonography of the extracranial carotid arteries to detect carotid atherosclerosis presence and to measure intima-media thickness.

Results

Mean age of the population was 50 ±12 years. Prevalence of the Carotid atherosclerosis was 40%. Mean carotid intima-media thickness was 0,66 ± 0,18 mm. The univariate and multivariate analysis showed an association between calcium and carotid intima-media thickness (p = 0,035). We divided the population in serum calcium tertiles. We found an higher carotid atherosclerosis prevalence in the III tertile in comparison to that of the I tertile (p = 0,039).

Conclusions

In this study we found a positive relation between serum calcium levels, within normal range, and subclinical atherosclerosis in the carotid arteries, in a population of obese/overweight subjects. It is important to consider the impact of the serum calcium levels in the overall risk assessment of patients, at least in obese subjects.

Keywords

Calcium Atherosclerosis Carotid Obesity Ultrasound

Background

Experimental studies suggested that calcium-phosphate metabolism could influence the pathogenesis of vascular diseases. In fact, several studies showed an increased cardiovascular morbidity and mortality in primary hyperparathyroidism (PHPT)[18]. Furthermore, increased carotid intima-media thickness (CIMT), a subclinical predictor of coronary and cerebrovascular events [912], was found in patients with PHPT and high calcium levels [13], suggesting a causative role of hypercalcemia. However, in most patients with PHPT, serum calcium levels is in normal range [9]. A study showed that serum calcium level, within the normal range, was positively associated to carotid atherosclerotic plaques presence [14]. Consequently, to date, the link between the serum calcium level and the cardiovascular diseases has not been fully elucidated. Furthermore, calcium and phosphate levels seem to exert differential effects, depending on the type and location of the vascular bed [15]. In particular it was demonstrated that calcium seems to affect specifically the cerebrovascular district [15]. For this reason our objective was to investigate on the possible relation between serum calcium levels, within normal range, and the presence of carotid atherosclerosis. Furthermore, since a recent research [16] proposing the participation of the calcium-sensing receptor (CaSR) as a possible link between obesity and inflammation, had attracted our attention, we chose to investigate the relation between calcium and carotid atherosclerosis in a population of overweight/obese subjects.

Methods

In our retrospective study participants were recruited from subjects underwent an health-screening tests in our hospital clinic for the presence of one or more cardiovascular risk factors (obesity, hyperlipidemia, hypertension, diabetes, smoking).

A total of 640 individuals, with at least one cardiovascular risk factor, underwent an ultrasonography of the carotid arteries during a period from the year 2008 to 2011. We excluded 168 normal weight individuals (40% males), therefore in this study 472 subjects (59% women; 41% men) were included. All individuals were Caucasian and underwent a collection of the medical history, by a standardized questionnaire administered to obtain information about current and past medication use, smoking habits and presence of cardiovascular disease. They underwent, also, a physical examination including the evaluation of the body mass index (BMI)(calculated as weight, in kg, divided by square of height, in meter); the measurement of the waist circumferences (WC)(a measuring tape was used for WC, measured right below the ribs); the measurement of the systemic blood pressure in both arms by a sphygmomanometer (systolic and diastolic blood pressure - SBP and DBP). The ankle-brachial systolic pressure index (Winsor Index) was determined by dividing the highest of the posterior tibial or dorsalis pedis systolic blood pressure by the highest brachial pressure. On the basis of the clinical history, no subjects had symptomatic cardiovascular disease.

Venous blood was collected after fasting overnight into vacutainer tubes (Becton & Dickinson) and centrifuged within 4 h. Serum glucose, creatinine, total cholesterol, high density lipoprotein cholesterol, triglycerides and calcium were measured with enzymatic colorimetric test (see Additional file 1: Supplemental materials). Serum Calcium were measured by Schwarzenbach test (see Additional file 1: Supplemental materials). Quality control was assessed daily for all determinations. The investigation conforms to the principles outlined in the Declaration of Helsinki. All patients provided informed consent to participate in our research and to use their data.

The following criteria were used to define the cardiovascular risk factors; diabetes: fasting blood glucose ≥126 mg/dl or antidiabetic treatment; hyperlipidemia: total cholesterol >200 mg/dl and/or triglycerides >200 mg/dl or lipid lowering drugs use; hypertension: systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg or antihypertensive treatment; smoking: present smokers; overweight: BMI ≥ 25 < 30 Kg/m2, obesity: BMI ≥ 30 kg/m2.

Ultrasound

The subjects underwent a B-mode ultrasonography of the extracranial carotid arteries by use of a duplex system (an high resolution ultrasound instrument “Advanced Technology Laboratories” -ATL, High Definition Imaging –HDI 5000 with a 5- to 12-MHz linear array multifrequency transducer). All the examinations were performed by the same ultrasonographer blinded to clinical information. All patients rested in the supine position for at least 10 min before the study and were kept in this position during the procedure. Electrocardiographic (ECG) leads were attached to the ultrasound recorder for on-line continuous heart rate monitoring. The right and left common (CCA) and internal carotid arteries (including bifurcations) were evaluated with the head of the subjects turned away from the sonographer and the neck extended with mild rotation. The CIMT, defined as the distance between the intimal–luminal interface and the medial–adventitial interface, was measured as previously described [17]. Briefly, in posterior approach and with the sound beam set perpendicular to the arterial surface, 1 cm from the bifurcation, three longitudinal measurements of IMT were completed on the right and left common carotid arteries far-wall, at sites free of any discrete plaques. The mean of the three right and left longitudinal measurements was then calculated. Then, we calculated and used for statistical analysis the mean CIMT between right and left CCA. Plaque, detected in longitudinal and transverse planes with anterior, lateral and posterior approaches, was defined as an echogenic focal structure encroaching into the vessel lumen of at least 50% of the surrounding CIMT value. Stenosis was defined as a peak systolic velocity >120 cm/s and occlusion was defined as absence of Doppler signal. According to these criteria, subjects were considered as normal if no lesion was detected, or having carotid atherosclerosis when a plaque, stenosis or occlusion was detected in at least one segment of common, bifurcation or internal carotid artery. The coefficient variation of the methods was 3.3%.

Statistical analysis

Data are reported as mean ± S.D. The χ 2-test was used to compare the prevalence among the groups. Univariate analysis was performed to identify the factors related to CIMT. The Multivariate regression analysis was performed to test for confounding variables and data were adjusted for gender. The Logistic regression analysis was used to test variables correlated to carotid atherosclerosis presence, including only the factors different at comparison (t-test) between subjects with and without carotid atherosclerosis. Furthermore, the χ 2-test was performed to compare the prevalence of the carotid atherosclerosis between “calcium tertiles” of population (between I and III tertile). Significant differences were assumed to be present at p < 0.05. All comparisons were performed using the SPSS 17.0 for Windows 233 S. Wacker Drive, Chicago, Illinois 60606, USA.

Results

The mean age of the population was 50 ± 12. The BMI was 33 ± 6. The characteristics of the overall population are showed in Table 1. Subjects treated with lipid lowering drugs were 28.6%. Table 2 shows the Multivariate regression analysis, adjusted for gender, including the variables correlated to CIMT at univariate analysis (age, glucose, SBP, DBP calcium, WC - data no showed). This analysis confirmed the association between calcium and CIMT, as well as, age, PAS, WC with CIMT (Table 2). In this population the prevalence of the Atherosclerotic was 40% (Table 1). After t-test between subjects with and without carotid atherosclerosis (Table 3), we performed a Logistic regression analysis with Carotid Atherosclerosis as dependent variable (Table 4). In this analysis, in the first two models performed, including age and gender (I model), and age, gender and WC (II model) calcium was correlated to Carotid Atherosclerosis. However, when (in the third model) glucose and SBP were included in the analysis, calcium was excluded (data no showed). Finally, we divided the population in serum calcium tertiles. Figure 1 depicts the higher carotid atherosclerosis prevalence of the III tertile in comparison to that of the I tertile (p = 0,039).
Table 1

Characteristics of the population

Variable

Mean

SD

Age (years)

50

12

BMI

33,3

5,9

Calcium (mg/dl)

9,4

0,4

Creatinine(mg/dl)

0,8

0,6

Glucose(mg/dl)

101

26

TCholesterol(mg/dl)

220

44

LDLcholesterol(mg/dl)

141

56

HDL(mg/dl)

50

14

Trygliceride(mg/dl)

174,46

106,9

CIMTmean (mm)

0,66

0,18

IWright

1,06

0,006

IWleft

1,07

0,007

Waist Circum(cm)

104,28

13,30

DBP(mmHg)

77,05

9,21

SBP (mmHg)

125,19

14,65

Carotid atherosclerosis (%)

40

 

diabetes(%)

9,7

 

Hyperlipidemia(%)

47

 

hypertension(%)

25,8

 

smokers(%)

7,4

 

Female (%)

59

 
Table 2

Multivariate regression analysis

Dependent Variable: CIMT

SE

Beta

t

p

Age

0,001

0,432

10,16

<0,001

SBP

0,001

0191

4,50

<0,001

WC

0,001

0,101

2,53

0,012

calcium

0,019

0,084

2,11

0,035

(the data are adjusted for gender)

Excluded variables: PAD, glucose (factors correlated to CIMT at univariate analysis-data no shown).

Table 3

Comparison ( t -test) between subjects with and without carotid atherosclerosis

Variables

Atherosclerosis presence

Atherosclerosis absence

p

AGE (years)

57,42 ± 8

45 ± 11

<0,001

SBP(mmHg)

129 ± 15

122 ± 14

<0,001

DBP(mmHg)

77 ± 10

77 ± 9

0,334

WC (cm)

103 ± 13

106 ± 14

0,049

BMI

32 ± 5

34 ± 6

<0,001

Calcium (mg/dl)

9,4 ± 0,3

9,3 ± 0,4

0,029

Tot cholesterol (mg/dl)

222 ± 46

217 ± 43

0,116

HDL (mg/dl)

51 ± 14

50 ± 13

0,413

Table 4

Logistic regression analysis

Dependent variable: Carotid Atherosclerosis

I model

Variable

B

S.E.

Wald

Sig

R

Exp(B)

AGE

0,15

0,01

95,23

<0,001

0,38

1,16

CALCIUM

0,63

0,30

4,34

0,03

0,06

1,89

GENDER

1,19

0,26

21,00

<0,001

0,17

3,29

II model

AGE

0,15

0,01

95,50

<0,001

0,38

1,16

CALCIUM

0,58

0,30

3,56

0,05

0,05

1,79

GENDER

1,28

0,26

23,11

<0,001

0,18

3,60

WC

−0,02

0,00

7,78

<0,001

−0,09

0,97

Figure 1

Carotid Atherosclerosis prevalence between calcium tertiles (p = 0,039).

Discussion

In this study we found a positive relation between serum calcium levels, within normal range, and CIMT. As expected,CIMT was, also, associated, to the classical risk factors like age, gender, glucose, SBP, DBP and WC. However, after adjustment for confounding factors in the multivariate analysis, the association between calcium and CIMT remained, as well as, for age, SBP and WC only (Table 2). Furthermore, in this study we showed an higher carotid atherosclerosis prevalence in the population group having high serum calcium level (III tertile)in comparison to group with low serum calcium level (I tertile) [Figure 1].

This study may have a relevant place among the studies already present in the literature since we evaluated a large number of subjects (472 individuals),with a BMI > 25 (overweight/obese) excluding subjects having pathological values of serum calcium. Furthermore, our study is important since investigated, at the same time, the relation between calcium and the various manifestations of the atherosclerotic process in the carotid district (i.e.: CIMT and plaques).

Similarly to other studies [12, 15, 18] the parathyroid hormone (PTH) measurement was not available. However, we had the objective to investigate on the possible association of serum calcium and subclinical atherosclerosis at carotid site, with others classical risk factors and not other factors.

Several investigations demonstrated the association between serum calcium and stroke, but not with coronary heart disease, in contrast to phosphate [15]. Although the cause of this divergence is uncertain, it was speculate that calcium-phosphate levels could exert differential effects, depending on the type and location of the vascular bed [15]. Thus, our finding is in line with the concept that the effects of the serum calcium are prominent for the cerebral district than for other sites [15].

The majority of cross-sectional studies indicated that elevated levels of established cardiovascular risk factors are associated with an increased CIMT [1921] including obesity and the insulin resistance condition. Certainly, our study was not designed to explain the mechanisms underlying the association finding in this study, however, some hypothesis may be advanced.

Several observations showed that serum calcium level, in the normal range, affect the risk of having Metabolic Syndrome (MetS) and diabetes [22]. This association may suggests a first possible mechanism by which calcium affect the intima-media thickness in our study, confirmed also by our finding of the strong relation between WC, a factor linked to MetS, and CIMT. Moreover, in our study there was a positive relation between serum calcium and glucose (p = 0,022; r = 0,166 - data no showed).

Furthermore, recently, Cifuentes et al. [16] reported that obesity-associated proinflammatory cytokines increased the CaSR protein expression in primary human adipocytes as well as in LS14 human adipose cell line. CaSR is a seven transmembrane receptor which plays a central role in regulating calcium homeostasis. In particular the activation of the CaSR maintains serum calcium at normal levels [23]. CaSR is a multifunctional protein inhibiting basal lipolysis in adipocytes [23], regulating the smooth muscle cells of vessels [24], involved also in the ischemic neuronal death [25]. All these observations could support the link between serum calcium, within normal range, and the CIMT. Furthermore, it was showed that obesity, as well as, the metabolic syndrome condition are associated to high level of serum fetuin-A, a protein playing an important role in bone metabolism, metabolic disorders, and central nervous system disorders such as ischemic stroke and neurodegenerative diseases [26, 27]. Actually it is unknown whether fetuin-A is an exacerbating or a protective factor in the cardiovascular system, however, it may represent the link between inflammation, calcium and atherosclerosis in obesity, needing further investigations.

Our study has several strengths and limitations. The study population was relatively large and the young population studied should be useful for the early identification of the subclinical carotid artery disease. Our study investigated, also, the various manifestations of the atherosclerotic process in the carotid district.

A limitation of our study, similarly to other studies [12, 18], may be that PTH and vitamin D levels were not available, as well as, fetuin A measurement.

Conclusions

We believe it is important to consider the impact of the serum calcium levels in the overall risk assessment of patients, at least in obese individuals. Despite a number of studies on this issue, actually the blood calcium level is considered a neglect risk factor for vasculature, thus, we think is important to perform other studies on this factor. It is unclear whether this finding will have a therapeutic implication. For now, it could clarify some morphological changes of specific vascular districts.

Funding

This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Abbreviation

PHPT: 

Primary hyperparathyroidism

CIMT: 

Carotid intima-media thickness

CaSR: 

Calcium-sensing receptor

BMI: 

Body mass index

WC: 

Waist circumferences

SBP: 

Systolic blood pressure

DBP: 

Diastolic blood pressure.

Declarations

Authors’ Affiliations

(1)
Clinical Nutrition Unit, Department of Medical and Surgical Science, School of Medicine, University Magna Grecia

References

  1. Palmér M, Adami HO, Bergström R, Akerström G, Ljunghall S: Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery. 1987, 102: 1-7.PubMedGoogle Scholar
  2. Hedback G, Oden A, Tisell LE: The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg. 1991, 15: 399-405. 10.1007/BF01658740.View ArticlePubMedGoogle Scholar
  3. Hedback G, Tisell LE, Bengtsson BA, Hedman I, Oden A: Premature death in patients operated on for primary hyperparathyroidism. World J Surg. 1990, 14: 829-835. 10.1007/BF01670531.View ArticlePubMedGoogle Scholar
  4. Hedbäck G, Oden A: Survival of patients operated on for primary hyperparathyroidism. Surgery. 1999, 125: 240-241. 10.1016/S0039-6060(99)70274-6.View ArticlePubMedGoogle Scholar
  5. Hedbäck G, Oden A: Increased risk of death from primary hyperparathyroidism: an update. Eur J Clin Invest. 1998, 28: 271-276. 10.1046/j.1365-2362.1998.00289.x.View ArticlePubMedGoogle Scholar
  6. Nilsson IL, Yin L, Lundgren E, Rastad J, Ekbom A: Clinical presentation of primary hyperparathyroidism in Europe: nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res. 2002, 17 (Suppl 2): N68-N74.PubMedGoogle Scholar
  7. Øgard CG, Engholm G, Almdal TP, Vestergaard H: Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977–1993 in Denmark. World J Surg. 2004, 28: 108-111. 10.1007/s00268-003-7046-0.View ArticlePubMedGoogle Scholar
  8. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon WM: Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med. 1998, 104: 115-122. 10.1016/S0002-9343(97)00270-2.View ArticlePubMedGoogle Scholar
  9. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JPA: 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999, 341: 1249-1255. 10.1056/NEJM199910213411701.View ArticlePubMedGoogle Scholar
  10. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ: Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000, 151: 478-487. 10.1093/oxfordjournals.aje.a010233.View ArticlePubMedGoogle Scholar
  11. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, WolfsonJr SK: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999, 340: 14-22. 10.1056/NEJM199901073400103.View ArticlePubMedGoogle Scholar
  12. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW: Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 1995, 26: 386-391. 10.1161/01.STR.26.3.386.View ArticlePubMedGoogle Scholar
  13. Nuzzo V, Tauchmanovà L, Fonderico F, Trotta R, Fittipaldi MR, Fontana D: Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol. 2002, 147: 453-459. 10.1530/eje.0.1470453.View ArticlePubMedGoogle Scholar
  14. Rubin MR, Rundek T, McMahon DJ, Lee HS, Sacco RL, Silverberg SJ: Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study. Atherosclerosis. 2007, 194: 426-432. 10.1016/j.atherosclerosis.2006.08.027.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Foley Robert N, Collins Allan J, AreefIshani , Kalra Philip A: Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2008, 156 (3): 556-563. 10.1016/j.ahj.2008.05.016.View ArticlePubMedGoogle Scholar
  16. Cifuentes M, Fuentes C, Mattar P, Tobar N, Hugo E, Ben-Jonathan N: Obesity-associated proinflammatory cytokines increase calciumsensing receptor (CaSR) protein expression in primary human adipocytes and LS14 human adipose cell line. Arch Biochem Biophys. 2010, 500: 151-156. 10.1016/j.abb.2010.05.033.View ArticlePubMedGoogle Scholar
  17. Pujia A, Gnasso A, Irace C, Colonna A, Mattioli PL: Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care. 1994, 17: 1330-6. 10.2337/diacare.17.11.1330.View ArticlePubMedGoogle Scholar
  18. White AD, Folsom AR, Chambless LE: Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J ClinEpidemiol. 1996, 49: 223-233.Google Scholar
  19. Walker MD, Fleischer J, Rundek T, McMahon DJ, Homma S, Sacco R: Carotid Vascular Abnormalities in Primary Hyperparathyroidism. J ClinEndocrinolMetab. 2009, 94: 3849-3856.View ArticleGoogle Scholar
  20. Bots ML, Iglesias del Sol A, Grobbee DE: Carotid intima-media thickness measurements in observational and intervention studies. CurrResVasc Dis. 1998, 3: 274-283.Google Scholar
  21. Fujii K, Abe I, Ohya Y, Onaka U, Tominaga M, Ohmori S: Association between hyperinsulinemia and intima-media thickness of the carotid artery in normotensive men. J Hypertens. 1997, 15: 167-172. 10.1097/00004872-199715020-00007.View ArticlePubMedGoogle Scholar
  22. Kim MK, Kim G, Jang EH, Kwon HS, Baek KH, Oh KW: Altered calcium homeostasis is correlated with the presence of metabolic syndromeand diabetes in middle-aged and elderly Korean subjects: the Chungju MetabolicDisease Cohort study (CMC study). Atherosclerosis. 2010, 212: 674-81. 10.1016/j.atherosclerosis.2010.07.005.View ArticlePubMedGoogle Scholar
  23. Yonghan He, Huaqi Zhang JianghuaTeng, Lina Huang, Ying Li, Changhao Sun: Involvement of calcium-sensing receptor in inhibition of lipolysis throughintracellular cAMP and calcium pathways in human adipocytes. Biochem Biophys Res Commun. 2011, 404: 393-399. 10.1016/j.bbrc.2010.11.129.View ArticleGoogle Scholar
  24. Chow JY, Estrema C, Orneles T, Dong X, Barrett KE, Dong H: Calcium-sensing receptor modulates extracellular Ca(2+) entry via TRPC-encoded receptor-operated channels in human aortic smooth muscle cells. Am J Physiol Cell Physiol. 2011, 301: C461-8. 10.1152/ajpcell.00389.2010.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Kim JY, Kim N, Yenari MA, Chang W: Mild Hypothermia Suppresses Calcium-Sensing Receptor (CaSR) Induction Following Forebrain Ischemia While Increasing GABA-B Receptor 1 (GABA-B-R1) Expression. Transl Stroke Res. 2011, 1;2: 195-201.View ArticleGoogle Scholar
  26. Brix JM, Stingl H, Höllerl F, Schernthaner GH, Kopp HP, Schernthaner G: Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J ClinEndocrinolMetab. 2010, 95: 4877-81.View ArticleGoogle Scholar
  27. Mori K, Emoto M, Inaba M: Fetuin-A and the cardiovascular system. AdvClin Chem. 2012, 56: 175-95.Google Scholar

Copyright

© Montalcini et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement